Navigation Links
Pharmaceutical Industry Confronting Big Challenges, Opportunities in 2012: Leaders to Convene at Groundbreaking Event on February 7-8 in New Jersey

PARSIPPANY, N.J., Jan. 11, 2012 /PRNewswire/ -- The year 2012 sets the stage for an exciting, yet challenging time for the pharmaceutical industry. To address what lies ahead in the New Year, the pharma industry's leading experts all plan to be at the Pharma Market Research Conference. This overwhelmingly popular event takes place on February 7-8 at the Hilton Parsippany Hotel in New Jersey.

Under the guidance of the esteemed advisory board with members from Alexion Pharmaceuticals, Bayer Healthcare, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Purdue Pharma, Shire Pharmaceuticals, Takeda Pharmaceuticals, Teva Health Systems and many more, the Pharma Market Research Conference is a prestigious event known for providing the best and latest information to all participants. This is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research.  To view the advisory board, go to:

Here's what one Merck executive said about the conference: "...a terrific opportunity to interact with fellow market research professionals and market research agencies in order to share best practices both for conducting market research and for how agencies and industry can most effectively interact. I came away feeling energized to try out new methodologies that I had learned about and to further familiarize myself with agencies that I met at the conference."

Time and time again, participants are overwhelmingly impressed with the Pharma Market Research Conference's outstanding program featuring an elite group of expert speakers who come from stellar companies like Abbott Laboratories, Alkermes, Allergan, Inc., Amylin Pharmaceuticals, Astellas Pharma, Auxilium Pharmaceuticals, Bayer Healthcare, Bristol-Myers Squibb, Cephalon, Covidien, Daiichi Sankyo, GE Healthcare Systems, GlaxoSmithKline, Johnson & Johnson, Lundbeck Inc., Mead Johnson, Merck, Millennium Pharmaceuticals, NPS Pharmaceuticals, Pfizer, Purdue Pharma, Roche, Shionogi Inc., Shire Pharmaceuticals, Takeda Pharmaceuticals, Teva Health, and many more! To view the detailed program agenda, go to:

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research. Nowhere else will you find the industry's best and brightest all under one roof!  More than 250 people came in 2011, and 2012 is expected to be even bigger and better.  For more information or to register, call + or go to:

Amy Yueh
Pharma Market Research Conference


SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/29/2015)... Los Angeles, Ca (PRWEB) , ... November 29, 2015 , ... ... from the American Board of Ophthalmology on November 25th 2015. Peer Certification ... in the field of his specialty. Certification in Ophthalmology is first obtained after the ...
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single IguanaMed scrub ... on Black Friday Target is offering a “Buy One Scrub Set, Get the 2nd ... opportunity to purchase IguanaMed at a discounted price. , IguanaMed’s mission is ...
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch ... BUDDY. "I conceived of this design due to personal experience with a bad back," ... promotes relaxation and convenience, as well as increases support. It also makes it easier ...
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... recent 2015 American Dental Association meeting in Washington D.C. revolved around the fact that ... patient’s overall health. The talk stressed the link between periodontal disease (more commonly referred ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
Breaking Medicine News(10 mins):